Biotechnology
Medical
Biopharmaceutical

Alder BioPharmaceuticals

$12.95
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$1.36 (-9.50%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell ALDR and other stocks, options, ETFs, and crypto commission-free!

About

Alder BioPharmaceuticals, Inc. Common Stock, also called Alder BioPharmaceuticals, is a clinical-stage biopharmaceutical company, which discovers, develops and commercializes various therapeutic antibodies. Read More Its product portfolio includes ALD1910, a preclinical product candidate also in development as a migraine prevention therapy. ALD1910 is a monoclonal antibody that inhibits pituitary adenylate cyclase-activating polypeptide-38 (PACAP-38), another protein that is active in mediating the initiation of migraine; and Clazakizumab, Alder's third program, is a monoclonal antibody candidate that inhibits interleukin-6. The company was founded by Randall C. Schatzman, Mark J. Litton, and John A. Latham in January 2004 and is headquartered in Bothell, WA.

Employees
202
Headquarters
Bothell, Washington
Founded
2004
Market Cap
885.92M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
968.62K
High Today
$14.18
Low Today
$12.87
Open Price
$14.06
Volume
446.30K
52 Week High
$20.87
52 Week Low
$9.44

Collections

Biotechnology
Medical
Biopharmaceutical
Pharmaceutical
Health
Therapy
Technology
2014 IPO

News

Seeking AlphaMar 5

Alder Biopharma closes stock offering and private placement

Alder BioPharmaceuticals (NASDAQ:ALDR) closes its previously announced public offering of 13M shares of common stock, priced at $11.50/share.

115
MarketBeatMar 1

Stock Price, News, & Analysis for Alder Biopharmaceuticals

News articles about ALDR stock have been trending somewhat positive on Wednesday, according to InfoTrie Sentiment. InfoTrie identifies negative and positive media coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Alder Biopharmaceuticals earned a media sentiment score of 1.2 on InfoTrie's scale. They also gave news coverage ab...

10
Seeking AlphaFeb 28

Alder Bio prices stock offering at $11.50; shares down 2% premarket

Alder BioPharmaceuticals (NASDAQ:ALDR) prices its public offering of ~11.3M shares of common stock at $11.50 per share. Underwriters over-allotment is an additional ~1.7M shares. Closing date is March 4. Yesterday's close was $12.21....

75

Earnings

-$1.73
-$1.42
-$1.11
-$0.80
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
Actual
Expected May 7, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.